Use of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin Secretion.
New biomarkers for type 2 diabetes mellitus (T2DM) may aid diagnosis, drug development or clinical treatment. Evidence is increasing for the adaptive immune system's role in T2DM and suggests the presence of unidentified autoantibodies. While high-density protein microarrays have emerged as a u...
Main Authors: | Douglas C Chang, Paolo Piaggi, Robert L Hanson, William C Knowler, John Bucci, Guene Thio, Maximilian G Hohenadel, Clifton Bogardus, Jonathan Krakoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4659622?pdf=render |
Similar Items
-
Prevalence of Autoantibodies and HLA DR, DQ in Type 1 Diabetes Mellitus
by: Shailja Singh, et al.
Published: (2016-07-01) -
Assessing accuracy of genotype imputation in American Indians.
by: Alka Malhotra, et al.
Published: (2014-01-01) -
Microarray ELISA for Autoantibody Screening in Connective Tissue Diseases
by: Sarita Kumble, et al.
Published: (2012-04-01) -
PREDICTIVE SIGNIFICANCE OF ANTI-HLA AUTOANTIBODIES IN HEART TRANSPLANT RECIPIENTS
by: O. P. Shevchenko, et al.
Published: (2014-05-01) -
The relationship between autoantibodies with HLA class II in Taiwanese IDDM
by: Lin, Chun-Ying, et al.
Published: (1997)